(Q53595048)

16 May 2018

title

Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. (English)

1 reference

16 May 2018

3

Hisashi Adachi

1 reference

16 May 2018

author name string

Kazuo Nakamura

1

1 reference

16 May 2018

Sho-ichi Yamagishi

2

1 reference

16 May 2018

Yayoi Kurita-Nakamura

4

1 reference

16 May 2018

Takanori Matsui

5

1 reference

16 May 2018

Takafumi Yoshida

6

1 reference

16 May 2018

Akira Sato

7

1 reference

16 May 2018

Tsutomu Imaizumi

8

1 reference

16 May 2018

publication date

1 July 2007

1 reference

16 May 2018

Diabetes - Metabolism: Research and Reviews

published in

1 reference

16 May 2018

volume

23

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

368-371

1 reference

16 May 2018

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

cites work

1 reference

Tissue-specific expression patterns of the RAGE receptor and its soluble forms—a result of regulated alternative splicing?

21 January 2018

1 reference

Advanced protein glycosylation in diabetes and aging

21 January 2018

1 reference

7 January 2021

Atherosclerosis and diabetes: the RAGE connection

1 reference

7 January 2021

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

1 reference

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

7 January 2021

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

7 January 2021

Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities.

1 reference

7 January 2021

Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus

1 reference

7 January 2021

Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension

1 reference

7 January 2021

Soluble Levels of Receptor for Advanced Glycation Endproducts (sRAGE) and Coronary Artery Disease

1 reference

7 January 2021

Upregulation of RAGE and its ligands in proliferative retinal disease

1 reference

7 January 2021

Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes

1 reference

7 January 2021

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications

1 reference

7 January 2021

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

1 reference

7 January 2021

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

1 reference

7 January 2021

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.690

1 reference

16 May 2018

PubMed ID

17024691

1 reference

16 May 2018